The key focus areas for 2020 are:

• Technologies to enhance the optical functionality of contact lenses for the correction of Presbyopia

• Strategies and Interventions to Slow Myopia Progression; with emphasis on:

• New technologies for treatment and management of myopia progression
• Myopia control solutions that are effective for fast progressors 
• Understanding environmental variables/factors that may initiate and prolong myopia progression
• Intelligent systems and big data approaches for identifying eyes at risk of developing myopia

Award Types

Research proposals may span proof-of-concept through translational stages. For this purpose, two types of awards are offered:

CooperVision Seedling Award
The CooperVision Seedling Award is intended to incentivize collaborations with CooperVision in a new research area for a one year period. The maximum total cash amount for a CooperVision seedling is $100,000.

CooperVision Translational Research Award
The CooperVision Translational Research Award is a multi-year award for a substantive translational research project with funding over two years, totaling up to $400,000.

Applicant Eligibility

Any researcher with Principal Investigator (PI) status holding a MD, OD, or PhD is eligible to apply. Applicants, such as postdoctoral fellows, with a waiver of PI status must submit appropriate documentation before funding can be received.


To Apply

Submission of a Letter of Intent (LOI)

Applicants must submit a LOI before June 12, 2020.  If the LOI is accepted, applicants will be notified and invited to submit a full proposal.

Proposal Submission
Upon approval of the LOI, applicants may submit a full proposal. The complete proposal must be submitted by the deadline July 31, 2020.


Please contact STAward@coopervision.com with questions.